Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Genetic variants in the TGFβ-signaling pathway influence expression of miRNAs in colon and rectal normal mucosa and tumor tissue.

Slattery ML, Trivellas A, Pellatt AJ, Mullany LE, Stevens JR, Wolff RK, Herrick JS.

Oncotarget. 2017 Mar 7;8(10):16765-16783. doi: 10.18632/oncotarget.14508.

2.

eIF3 controls cell size independently of S6K1-activity.

Schipany K, Rosner M, Ionce L, Hengstschläger M, Kovacic B.

Oncotarget. 2015 Sep 15;6(27):24361-75.

3.

Eukaryotic Translation Initiation Factor 4E Is a Feed-Forward Translational Coactivator of Transforming Growth Factor β Early Protransforming Events in Breast Epithelial Cells.

Decarlo L, Mestel C, Barcellos-Hoff MH, Schneider RJ.

Mol Cell Biol. 2015 Aug;35(15):2597-609. doi: 10.1128/MCB.00324-15. Epub 2015 May 18.

4.

EIF6 over-expression increases the motility and invasiveness of cancer cells by modulating the expression of a critical subset of membrane-bound proteins.

Pinzaglia M, Montaldo C, Polinari D, Simone M, La Teana A, Tripodi M, Mancone C, Londei P, Benelli D.

BMC Cancer. 2015 Mar 15;15:131. doi: 10.1186/s12885-015-1106-3.

5.

A novel Bcr-Abl-mTOR-eIF4A axis regulates IRES-mediated translation of LEF-1.

Tsai BP, Jimenez J, Lim S, Fitzgerald KD, Zhang M, Chuah CT, Axelrod H, Wilson L, Ong ST, Semler BL, Waterman ML.

Open Biol. 2014 Nov;4(11):140180. doi: 10.1098/rsob.140180.

6.

Transimulation - protein biosynthesis web service.

Siwiak M, Zielenkiewicz P.

PLoS One. 2013 Sep 5;8(9):e73943. doi: 10.1371/journal.pone.0073943. eCollection 2013.

7.

Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules.

Rizvi I, Gurkan UA, Tasoglu S, Alagic N, Celli JP, Mensah LB, Mai Z, Demirci U, Hasan T.

Proc Natl Acad Sci U S A. 2013 May 28;110(22):E1974-83. doi: 10.1073/pnas.1216989110. Epub 2013 May 3.

8.

Identification of global alteration of translational regulation in glioma in vivo.

Helmy K, Halliday J, Fomchenko E, Setty M, Pitter K, Hafemeister C, Holland EC.

PLoS One. 2012;7(10):e46965. doi: 10.1371/journal.pone.0046965. Epub 2012 Oct 3.

9.

Attacking a nexus of the oncogenic circuitry by reversing aberrant eIF4F-mediated translation.

Bitterman PB, Polunovsky VA.

Mol Cancer Ther. 2012 May;11(5):1051-61. doi: 10.1158/1535-7163.MCT-11-0530. Review.

10.

Genetic variation in the transforming growth factor-β-signaling pathway, lifestyle factors, and risk of colon or rectal cancer.

Slattery ML, Lundgreen A, Wolff RK, Herrick JS, Caan BJ.

Dis Colon Rectum. 2012 May;55(5):532-40. doi: 10.1097/DCR.0b013e31824b5feb.

11.

The translation factor eIF6 is a Notch-dependent regulator of cell migration and invasion.

Benelli D, Cialfi S, Pinzaglia M, Talora C, Londei P.

PLoS One. 2012;7(2):e32047. doi: 10.1371/journal.pone.0032047. Epub 2012 Feb 14.

12.

Targeting translation dependence in cancer.

Malina A, Cencic R, Pelletier J.

Oncotarget. 2011 Jan-Feb;2(1-2):76-88. Review.

13.

Genetic variation in the transforming growth factor-β signaling pathway and survival after diagnosis with colon and rectal cancer.

Slattery ML, Lundgreen A, Herrick JS, Wolff RK, Caan BJ.

Cancer. 2011 Sep 15;117(18):4175-83. doi: 10.1002/cncr.26018. Epub 2011 Mar 1.

14.

Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and riskof colon and rectal cancer: additional support for a TGF-β-signaling pathway.

Slattery ML, Lundgreen A, Herrick JS, Caan BJ, Potter JD, Wolff RK.

Carcinogenesis. 2011 Mar;32(3):318-26. doi: 10.1093/carcin/bgq245. Epub 2010 Nov 18.

15.

The RNA binding protein HuR differentially regulates unique subsets of mRNAs in estrogen receptor negative and estrogen receptor positive breast cancer.

Calaluce R, Gubin MM, Davis JW, Magee JD, Chen J, Kuwano Y, Gorospe M, Atasoy U.

BMC Cancer. 2010 Apr 6;10:126. doi: 10.1186/1471-2407-10-126.

16.

Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations.

Brennan C, Momota H, Hambardzumyan D, Ozawa T, Tandon A, Pedraza A, Holland E.

PLoS One. 2009 Nov 13;4(11):e7752. doi: 10.1371/journal.pone.0007752.

17.

The complex regulation of HIC (Human I-mfa domain containing protein) expression.

Reiss-Sklan E, Levitzki A, Naveh-Many T.

PLoS One. 2009 Jul 7;4(7):e6152. doi: 10.1371/journal.pone.0006152.

18.

Stress-dependent coordination of transcriptome and translatome in yeast.

Halbeisen RE, Gerber AP.

PLoS Biol. 2009 May;7(5):e1000105. doi: 10.1371/journal.pbio.1000105. Epub 2009 May 5.

19.

The EGFR-GEP100-Arf6-AMAP1 signaling pathway specific to breast cancer invasion and metastasis.

Sabe H, Hashimoto S, Morishige M, Ogawa E, Hashimoto A, Nam JM, Miura K, Yano H, Onodera Y.

Traffic. 2009 Aug;10(8):982-93. doi: 10.1111/j.1600-0854.2009.00917.x. Epub 2009 Apr 21. Review.

20.

Posttranscriptional regulation of p53 and its targets by RNA-binding proteins.

Zhang J, Chen X.

Curr Mol Med. 2008 Dec;8(8):845-9. Review.

Supplemental Content

Support Center